Intended for healthcare professionals


US AIDS activists urge caution on new anti-HIV drugs

BMJ 1994; 309 doi: (Published 24 September 1994) Cite this as: BMJ 1994;309:757
  1. J Roberts

    Three years ago AIDS activists successfully petitioned the US government to accelerate the approval of drugs that showed promise against HIV. Last week many of them asked the government to drop the new system that has allowed at least three anti-HIV drugs to get on to the market faster. The Food and Drug Administration (FDA) spent two days hearing from both sides of a debate that basically comes down to this. If you have a life threatening disease do you want to take a drug that is proved effective, even if you have to wait for two or three years, or would you rather try an unproved drug …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription